$22.39
0.813.75%
At close: -
$22.39
0.000.00%
After Hours: 4:00 PM EDT
Cidara Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Cidara Therapeutics using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
CDTX | Cidara Therapeutics | -$2.28 | -$4.26 | — | — | $8.46M | — | — | — | 05/14/2025 | Get Alert |
CDTX | Cidara Therapeutics | -$0.80 | -$4.10 | -$5.38 | -31.22% | $17.58M | $300.00K | $0.00 | -100.00% | 03/06/2025 | Get Alert |
CDTX | Cidara Therapeutics | -$1.80 | -$4.25 | -$2.38 | 44.00% | $12.72M | $430.00K | $0.00 | -100.00% | 11/07/2024 | Get Alert |
CDTX | Cidara Therapeutics | -$2.80 | -$4.10 | -$2.05 | 50.00% | $7.61M | $4.70M | $302.00K | -93.57% | 08/13/2024 | Get Alert |
CDTX | Cidara Therapeutics | $0.60 | -$0.80 | -$2.28 | -185.00% | $25.99M | $9.03M | $8.46M | -6.28% | 05/15/2024 | Get Alert |
CDTX | Cidara Therapeutics | -$3.80 | -$2.00 | -$0.80 | 60.00% | $10.22M | $11.54M | $17.58M | 52.37% | 04/22/2024 | Get Alert |
CDTX | Cidara Therapeutics | $3.40 | -$3.20 | -$1.80 | 43.75% | $40.74M | $8.14M | $12.72M | 56.24% | 11/02/2023 | Get Alert |
CDTX | Cidara Therapeutics | -$3.80 | -$2.60 | -$2.80 | -7.69% | $6.22M | $11.55M | $7.61M | -34.08% | 08/03/2023 | Get Alert |
CDTX | Cidara Therapeutics | -$5.40 | $0.80 | $0.60 | -25.00% | $7.11M | $18.68M | $25.99M | 39.13% | 05/11/2023 | Get Alert |
CDTX | Cidara Therapeutics | -$5.20 | -$3.40 | -$3.80 | -11.76% | $7.22M | $10.57M | $10.22M | -3.32% | 03/23/2023 | Get Alert |
CDTX | Cidara Therapeutics | -$7.40 | $3.60 | $3.40 | -5.56% | $7.08M | $35.67M | $40.74M | 14.22% | 11/03/2022 | Get Alert |
CDTX | Cidara Therapeutics | $3.60 | -$5.60 | -$3.80 | 32.14% | $32.86M | $6.21M | $6.22M | 0.10% | 08/09/2022 | Get Alert |
CDTX | Cidara Therapeutics | -$7.80 | -$5.80 | -$5.40 | 6.90% | $2.41M | $6.11M | $7.11M | 16.35% | 05/11/2022 | Get Alert |
CDTX | Cidara Therapeutics | -$9.80 | -$6.80 | -$5.20 | 23.53% | $3.73M | $4.31M | $7.22M | 67.63% | 03/07/2022 | Get Alert |
CDTX | Cidara Therapeutics | -$8.20 | -$7.20 | -$7.40 | -2.78% | $2.42M | $2.94M | $7.08M | 140.68% | 11/10/2021 | Get Alert |
CDTX | Cidara Therapeutics | -$9.00 | -$1.60 | $3.60 | 325.00% | $3.39M | $18.20M | $32.86M | 80.57% | 08/12/2021 | Get Alert |
CDTX | Cidara Therapeutics | -$9.20 | -$6.20 | -$7.80 | -25.81% | $2.53M | $8.33M | $2.41M | -71.09% | 05/13/2021 | Get Alert |
CDTX | Cidara Therapeutics | -$8.40 | — | -$9.80 | — | $1.81M | — | $3.73M | — | 02/25/2021 | Get Alert |
CDTX | Cidara Therapeutics | $1.60 | — | -$8.20 | — | $19.10M | — | $2.42M | — | 11/05/2020 | Get Alert |
CDTX | Cidara Therapeutics | -$9.40 | — | -$9.00 | — | $0.00 | — | $3.39M | — | 08/13/2020 | Get Alert |
CDTX | Cidara Therapeutics | -$11.60 | — | -$9.20 | — | $0.00 | — | $2.53M | — | 05/13/2020 | Get Alert |
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q4 | 2025-03-06 | $-5.38 | $-4.10 | -31.2 % |
Q3 | 2024-11-07 | $-2.38 | $-4.25 | 44.0 % |
Q2 | 2024-08-13 | $-2.05 | $-4.10 | 50.0 % |
Q1 | 2024-05-15 | $-2.28 | $-0.80 | -185.0 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q4 | 2025-03-06 | $0 | $300.00K | -100.0 % |
Q3 | 2024-11-07 | $0 | $430.00K | -100.0 % |
Q2 | 2024-08-13 | $302.00K | $4.70M | -93.6 % |
Q1 | 2024-05-15 | $8.46M | $9.03M | -6.28 % |
Cidara Therapeutics (CDTX) is scheduled to report earnings on May 14, 2025. The last reported earnings were for reported on March 6, 2025 for Q4.
The Actual EPS was $-5.38, which missed the estimate of $-4.10.
The Actual Revenue was $0K, which missed the estimate of $300K.
Browse earnings estimates, EPS, and revenue on all stocks.